カテゴリー： Market Monitor Global, 世界, 医療/バイオ

処方呼吸器薬の世界市場見通し2023年-2029年

◆英語タイトル：Prescription Respiratory Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8600 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：79 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Prescription Respiratory Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの処方呼吸器薬市場規模と予測を収録しています。・世界の処方呼吸器薬市場：売上、2018年-2023年、2024年-2029年
・世界の処方呼吸器薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の処方呼吸器薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「抗炎症薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

処方呼吸器薬のグローバル主要企業は、AstraZeneca、 Boehringer Ingelheim、 GlaxoSmithKline、 Merckなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、処方呼吸器薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の処方呼吸器薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の処方呼吸器薬市場：タイプ別市場シェア、2022年
・抗炎症薬、マスト安定薬、抗ヒスタミン薬、気管支拡張薬、その他

世界の処方呼吸器薬市場：用途別、2018年-2023年、2024年-2029年
世界の処方呼吸器薬市場：用途別市場シェア、2022年
・病院薬局、ドラッグストア、小売店、Eコマース

世界の処方呼吸器薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の処方呼吸器薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における処方呼吸器薬のグローバル売上、2018年-2023年
・主要企業における処方呼吸器薬のグローバル売上シェア、2022年
・主要企業における処方呼吸器薬のグローバル販売量、2018年-2023年
・主要企業における処方呼吸器薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AstraZeneca、 Boehringer Ingelheim、 GlaxoSmithKline、 Merck

*************************************************************

・調査・分析レポートの概要
処方呼吸器薬市場の定義
市場セグメント
世界の処方呼吸器薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の処方呼吸器薬市場規模
世界の処方呼吸器薬市場規模：2022年 VS 2029年
世界の処方呼吸器薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの処方呼吸器薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の処方呼吸器薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：抗炎症薬、マスト安定薬、抗ヒスタミン薬、気管支拡張薬、その他
処方呼吸器薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、ドラッグストア、小売店、Eコマース
処方呼吸器薬の用途別グローバル売上・予測

・地域別市場分析
地域別処方呼吸器薬市場規模 2022年と2029年
地域別処方呼吸器薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AstraZeneca、 Boehringer Ingelheim、 GlaxoSmithKline、 Merck
...

A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed.
This report aims to provide a comprehensive presentation of the global market for Prescription Respiratory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prescription Respiratory Drugs. This report contains market size and forecasts of Prescription Respiratory Drugs in global, including the following market information:
Global Prescription Respiratory Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prescription Respiratory Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prescription Respiratory Drugs companies in 2022 (%)
The global Prescription Respiratory Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anti-Inflammatories Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prescription Respiratory Drugs include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prescription Respiratory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prescription Respiratory Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Respiratory Drugs Market Segment Percentages, by Type, 2022 (%)
Anti-Inflammatories
Mast Stabilizers
Antihistamines
Bronchodilators
Other Respiratory Drugs
Global Prescription Respiratory Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Respiratory Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Drug Stores
Retail Stores
E-Commerce
Global Prescription Respiratory Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prescription Respiratory Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prescription Respiratory Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prescription Respiratory Drugs revenues share in global market, 2022 (%)
Key companies Prescription Respiratory Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prescription Respiratory Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Boehringer Ingelheim
GlaxoSmithKline
Merck
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prescription Respiratory Drugs, market overview.
Chapter 2: Global Prescription Respiratory Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Prescription Respiratory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prescription Respiratory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prescription Respiratory Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prescription Respiratory Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prescription Respiratory Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prescription Respiratory Drugs Overall Market Size
2.1 Global Prescription Respiratory Drugs Market Size: 2022 VS 2029
2.2 Global Prescription Respiratory Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prescription Respiratory Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Prescription Respiratory Drugs Players in Global Market
3.2 Top Global Prescription Respiratory Drugs Companies Ranked by Revenue
3.3 Global Prescription Respiratory Drugs Revenue by Companies
3.4 Global Prescription Respiratory Drugs Sales by Companies
3.5 Global Prescription Respiratory Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prescription Respiratory Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prescription Respiratory Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prescription Respiratory Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prescription Respiratory Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prescription Respiratory Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prescription Respiratory Drugs Market Size Markets, 2022 & 2029
4.1.2 Anti-Inflammatories
4.1.3 Mast Stabilizers
4.1.4 Antihistamines
4.1.5 Bronchodilators
4.1.6 Other Respiratory Drugs
4.2 By Type – Global Prescription Respiratory Drugs Revenue & Forecasts
4.2.1 By Type – Global Prescription Respiratory Drugs Revenue, 2018-2023
4.2.2 By Type – Global Prescription Respiratory Drugs Revenue, 2024-2029
4.2.3 By Type – Global Prescription Respiratory Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Prescription Respiratory Drugs Sales & Forecasts
4.3.1 By Type – Global Prescription Respiratory Drugs Sales, 2018-2023
4.3.2 By Type – Global Prescription Respiratory Drugs Sales, 2024-2029
4.3.3 By Type – Global Prescription Respiratory Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Prescription Respiratory Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prescription Respiratory Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Drug Stores
5.1.4 Retail Stores
5.1.5 E-Commerce
5.2 By Application – Global Prescription Respiratory Drugs Revenue & Forecasts
5.2.1 By Application – Global Prescription Respiratory Drugs Revenue, 2018-2023
5.2.2 By Application – Global Prescription Respiratory Drugs Revenue, 2024-2029
5.2.3 By Application – Global Prescription Respiratory Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Prescription Respiratory Drugs Sales & Forecasts
5.3.1 By Application – Global Prescription Respiratory Drugs Sales, 2018-2023
5.3.2 By Application – Global Prescription Respiratory Drugs Sales, 2024-2029
5.3.3 By Application – Global Prescription Respiratory Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Prescription Respiratory Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prescription Respiratory Drugs Market Size, 2022 & 2029
6.2 By Region – Global Prescription Respiratory Drugs Revenue & Forecasts
6.2.1 By Region – Global Prescription Respiratory Drugs Revenue, 2018-2023
6.2.2 By Region – Global Prescription Respiratory Drugs Revenue, 2024-2029
6.2.3 By Region – Global Prescription Respiratory Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Prescription Respiratory Drugs Sales & Forecasts
6.3.1 By Region – Global Prescription Respiratory Drugs Sales, 2018-2023
6.3.2 By Region – Global Prescription Respiratory Drugs Sales, 2024-2029
6.3.3 By Region – Global Prescription Respiratory Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prescription Respiratory Drugs Revenue, 2018-2029
6.4.2 By Country – North America Prescription Respiratory Drugs Sales, 2018-2029
6.4.3 US Prescription Respiratory Drugs Market Size, 2018-2029
6.4.4 Canada Prescription Respiratory Drugs Market Size, 2018-2029
6.4.5 Mexico Prescription Respiratory Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prescription Respiratory Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Prescription Respiratory Drugs Sales, 2018-2029
6.5.3 Germany Prescription Respiratory Drugs Market Size, 2018-2029
6.5.4 France Prescription Respiratory Drugs Market Size, 2018-2029
6.5.5 U.K. Prescription Respiratory Drugs Market Size, 2018-2029
6.5.6 Italy Prescription Respiratory Drugs Market Size, 2018-2029
6.5.7 Russia Prescription Respiratory Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Prescription Respiratory Drugs Market Size, 2018-2029
6.5.9 Benelux Prescription Respiratory Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prescription Respiratory Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Prescription Respiratory Drugs Sales, 2018-2029
6.6.3 China Prescription Respiratory Drugs Market Size, 2018-2029
6.6.4 Japan Prescription Respiratory Drugs Market Size, 2018-2029
6.6.5 South Korea Prescription Respiratory Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Prescription Respiratory Drugs Market Size, 2018-2029
6.6.7 India Prescription Respiratory Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prescription Respiratory Drugs Revenue, 2018-2029
6.7.2 By Country – South America Prescription Respiratory Drugs Sales, 2018-2029
6.7.3 Brazil Prescription Respiratory Drugs Market Size, 2018-2029
6.7.4 Argentina Prescription Respiratory Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prescription Respiratory Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prescription Respiratory Drugs Sales, 2018-2029
6.8.3 Turkey Prescription Respiratory Drugs Market Size, 2018-2029
6.8.4 Israel Prescription Respiratory Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Prescription Respiratory Drugs Market Size, 2018-2029
6.8.6 UAE Prescription Respiratory Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Prescription Respiratory Drugs Major Product Offerings
7.1.4 AstraZeneca Prescription Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Prescription Respiratory Drugs Major Product Offerings
7.2.4 Boehringer Ingelheim Prescription Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Prescription Respiratory Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Prescription Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Prescription Respiratory Drugs Major Product Offerings
7.4.4 Merck Prescription Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Merck Key News & Latest Developments
8 Global Prescription Respiratory Drugs Production Capacity, Analysis
8.1 Global Prescription Respiratory Drugs Production Capacity, 2018-2029
8.2 Prescription Respiratory Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prescription Respiratory Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prescription Respiratory Drugs Supply Chain Analysis
10.1 Prescription Respiratory Drugs Industry Value Chain
10.2 Prescription Respiratory Drugs Upstream Market
10.3 Prescription Respiratory Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prescription Respiratory Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prescription Respiratory Drugs in Global Market
Table 2. Top Prescription Respiratory Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prescription Respiratory Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prescription Respiratory Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Prescription Respiratory Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Prescription Respiratory Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prescription Respiratory Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Prescription Respiratory Drugs Product Type
Table 9. List of Global Tier 1 Prescription Respiratory Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prescription Respiratory Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prescription Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prescription Respiratory Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prescription Respiratory Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prescription Respiratory Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Prescription Respiratory Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Prescription Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prescription Respiratory Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prescription Respiratory Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prescription Respiratory Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Prescription Respiratory Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Prescription Respiratory Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prescription Respiratory Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prescription Respiratory Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prescription Respiratory Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Prescription Respiratory Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prescription Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prescription Respiratory Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Prescription Respiratory Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prescription Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prescription Respiratory Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prescription Respiratory Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prescription Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prescription Respiratory Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prescription Respiratory Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prescription Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prescription Respiratory Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Prescription Respiratory Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prescription Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prescription Respiratory Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prescription Respiratory Drugs Sales, (K Units), 2024-2029
Table 46. AstraZeneca Company Summary
Table 47. AstraZeneca Prescription Respiratory Drugs Product Offerings
Table 48. AstraZeneca Prescription Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. AstraZeneca Key News & Latest Developments
Table 50. Boehringer Ingelheim Company Summary
Table 51. Boehringer Ingelheim Prescription Respiratory Drugs Product Offerings
Table 52. Boehringer Ingelheim Prescription Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Boehringer Ingelheim Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Prescription Respiratory Drugs Product Offerings
Table 56. GlaxoSmithKline Prescription Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Prescription Respiratory Drugs Product Offerings
Table 60. Merck Prescription Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck Key News & Latest Developments
Table 62. Prescription Respiratory Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 63. Global Prescription Respiratory Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Prescription Respiratory Drugs Production by Region, 2018-2023 (K Units)
Table 65. Global Prescription Respiratory Drugs Production by Region, 2024-2029 (K Units)
Table 66. Prescription Respiratory Drugs Market Opportunities & Trends in Global Market
Table 67. Prescription Respiratory Drugs Market Drivers in Global Market
Table 68. Prescription Respiratory Drugs Market Restraints in Global Market
Table 69. Prescription Respiratory Drugs Raw Materials
Table 70. Prescription Respiratory Drugs Raw Materials Suppliers in Global Market
Table 71. Typical Prescription Respiratory Drugs Downstream
Table 72. Prescription Respiratory Drugs Downstream Clients in Global Market
Table 73. Prescription Respiratory Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prescription Respiratory Drugs Segment by Type in 2022
Figure 2. Prescription Respiratory Drugs Segment by Application in 2022
Figure 3. Global Prescription Respiratory Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prescription Respiratory Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prescription Respiratory Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Prescription Respiratory Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prescription Respiratory Drugs Revenue in 2022
Figure 9. By Type - Global Prescription Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Prescription Respiratory Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Prescription Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Prescription Respiratory Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Prescription Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prescription Respiratory Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 23. US Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 28. Germany Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 37. China Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prescription Respiratory Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prescription Respiratory Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prescription Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prescription Respiratory Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prescription Respiratory Drugs by Region, 2022 VS 2029
Figure 54. Prescription Respiratory Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 処方呼吸器薬の世界市場見通し2023年-2029年(Prescription Respiratory Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

処方呼吸器薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp